Gagnon Neil
|
Non-Executive |
POWER SOLUTIONS INTERNATIONAL, INC. (PSIX)
|
2024-01-24 |
$1.87 |
934.3% |
$6,086
|
348
|
$651 |
Gagnon Neil
|
Non-Executive |
POWER SOLUTIONS INTERNATIONAL, INC. (PSIX)
|
2024-02-29 |
$1.95 |
893.2% |
$436,469
|
25,069
|
$48,867 |
Gagnon Neil
|
Non-Executive |
POWER SOLUTIONS INTERNATIONAL, INC. (PSIX)
|
2024-02-12 |
$1.99 |
872.1% |
$15,197
|
875
|
$1,743 |
Gagnon Neil
|
Non-Executive |
POWER SOLUTIONS INTERNATIONAL, INC. (PSIX)
|
2024-03-22 |
$2.00 |
868.0% |
$22,933
|
1,321
|
$2,642 |
Gagnon Neil
|
Non-Executive |
POWER SOLUTIONS INTERNATIONAL, INC. (PSIX)
|
2024-04-25 |
$2.00 |
868.0% |
$155,042
|
8,931
|
$17,862 |
Gagnon Neil
|
Non-Executive |
POWER SOLUTIONS INTERNATIONAL, INC. (PSIX)
|
2024-03-12 |
$2.00 |
868.0% |
$118,343
|
6,817
|
$13,634 |
Gagnon Neil
|
Non-Executive |
POWER SOLUTIONS INTERNATIONAL, INC. (PSIX)
|
2024-03-20 |
$2.00 |
868.0% |
$93,605
|
5,392
|
$10,784 |
Gagnon Neil
|
Non-Executive |
POWER SOLUTIONS INTERNATIONAL, INC. (PSIX)
|
2024-04-30 |
$2.00 |
868.0% |
$1,347,449
|
77,618
|
$155,236 |
Gagnon Neil
|
Non-Executive |
POWER SOLUTIONS INTERNATIONAL, INC. (PSIX)
|
2024-02-20 |
$2.00 |
868.0% |
$16,943
|
976
|
$1,952 |
Maggiore Christopher D.
|
Non-Executive Director |
Zivo Bioscience, Inc. (ZIVO)
|
2023-12-29 |
$1.30 |
669.2% |
$1,371,920
|
157,692
|
$205,000 |
Avalon Ventures Xi, L.P.
|
Non-Executive |
Janux Therapeutics, Inc. (JANX)
|
2023-11-13 |
$5.87 |
644.6% |
$32,158,475
|
849,854
|
$4,988,643 |
Reardon Tighe
|
Acting Chief Financial Officer |
Janux Therapeutics, Inc. (JANX)
|
2023-11-13 |
$5.87 |
644.6% |
$32,158,475
|
849,854
|
$4,988,643 |
Lichter Jay
|
Non-Executive Director |
Janux Therapeutics, Inc. (JANX)
|
2023-11-13 |
$5.87 |
644.6% |
$32,158,475
|
849,854
|
$4,988,643 |
Toghraie Jeff
|
Chairman, CEO |
Reviv3 Procare Co (RVIV)
|
2023-10-18 |
$2.40 |
434.2% |
$1,094,100
|
105,000
|
$252,000 |
Decheng Capital Global Healthcare Fund (Master), Lp
|
Non-Executive |
ALPINE IMMUNE SCIENCES, INC. (ALPN)
|
2023-11-09 |
$12.50 |
419.8% |
$19,676,250
|
375,000
|
$4,687,500 |
Cui Xiangmin
|
Non-Executive Director |
ALPINE IMMUNE SCIENCES, INC. (ALPN)
|
2023-11-09 |
$12.50 |
419.8% |
$19,676,250
|
375,000
|
$4,687,500 |
Opaleye Management Inc.
|
Non-Executive |
HARROW, INC. (HROW)
|
2023-11-15 |
$8.03 |
398.7% |
$800,265
|
25,000
|
$200,735 |
Frazier Life Sciences Viii, L.P.
|
Non-Executive |
Arcutis Biotherapeutics, Inc. (ARQT)
|
2023-10-24 |
$2.50 |
333.2% |
$666,400
|
80,000
|
$200,000 |
Chae James
|
CEO |
Yoshiharu Global Co. (YOSH)
|
2023-09-13 |
$1.07 |
324.9% |
$69,860
|
20,000
|
$21,500 |
Opaleye Management Inc.
|
Non-Executive |
HARROW, INC. (HROW)
|
2024-03-20 |
$9.65 |
314.9% |
$1,537,734
|
50,600
|
$488,290 |
Opaleye Management Inc.
|
Non-Executive |
HARROW, INC. (HROW)
|
2024-04-25 |
$9.97 |
301.6% |
$601,400
|
20,000
|
$199,400 |
Cormorant Asset Management, Lp
|
Non-Executive |
Ambrx Biopharma, Inc. (AMAM)
|
2023-10-23 |
$6.99 |
300.5% |
$27,465,166
|
1,307,311
|
$9,139,542 |
Opaleye Management Inc.
|
Non-Executive |
HARROW, INC. (HROW)
|
2024-04-24 |
$10.23 |
291.3% |
$596,160
|
20,000
|
$204,640 |
Chae James
|
CEO |
Yoshiharu Global Co. (YOSH)
|
2023-12-14 |
$1.20 |
280.7% |
$848,736
|
252,000
|
$302,400 |
Opaleye Management Inc.
|
Non-Executive |
HARROW, INC. (HROW)
|
2024-04-19 |
$10.56 |
279.3% |
$866,786
|
29,400
|
$310,390 |
Moradi David
|
CHIEF EXECUTIVE OFFICER |
AUDIOEYE INC (AEYE)
|
2023-09-15 |
$5.59 |
274.0% |
$458,536
|
29,947
|
$167,356 |
Casdin Capital, Llc
|
Non-Executive Director |
GeneDx Holdings Corp. (WGS)
|
2024-03-05 |
$8.74 |
273.0% |
$976,506
|
40,900
|
$357,652 |
Telegraph Hill Partners Iv, L.P.
|
Non-Executive |
Alpha Teknova, Inc. (TKNO)
|
2024-07-12 |
$1.24 |
269.4% |
$40,403,222
|
12,096,773
|
$14,999,999 |
Katmandu Ventures, Llc
|
Non-Executive |
Falcon's Beyond Global, Inc. (FBYD)
|
2024-06-14 |
$3.02 |
257.2% |
$16,247,227
|
2,095,087
|
$6,316,862 |
B. Riley Financial, Inc.
|
Non-Executive |
SYNCHRONOSS TECHNOLOGIES INC (SNCR)
|
2023-11-13 |
$4.01 |
250.5% |
$636,858
|
63,330
|
$254,199 |
B. Riley Financial, Inc.
|
Non-Executive |
SYNCHRONOSS TECHNOLOGIES INC (SNCR)
|
2023-11-14 |
$4.05 |
247.4% |
$82,597
|
8,243
|
$33,385 |
Viking Global Investors Lp
|
Non-Executive |
RayzeBio, Inc. (RYZB)
|
2023-09-19 |
$18.00 |
247.2% |
$61,791,674
|
1,388,889
|
$25,000,002 |
Viking Global Investors Lp
|
Non-Executive |
RayzeBio, Inc. (RYZB)
|
2023-09-19 |
$18.00 |
247.2% |
$61,791,674
|
1,388,889
|
$25,000,002 |
Levan Jarett
|
CEO and President |
BBX Capital, Inc. (B)
|
2024-02-02 |
$11.08 |
240.0% |
$11,045,352
|
415,395
|
$4,602,577 |
Encrantz Staffan
|
Non-Executive Director |
Sight Sciences, Inc. (SGHT)
|
2023-11-14 |
$2.00 |
221.0% |
$15,278
|
3,462
|
$6,914 |
Nerges Joseph R
|
Non-Executive |
CSP INC /MA/ (CSPI)
|
2023-09-05 |
$3.92 |
212.9% |
$62,567
|
7,488
|
$29,386 |
Opaleye Management Inc.
|
Non-Executive |
HARROW, INC. (HROW)
|
2024-03-28 |
$12.82 |
212.3% |
$1,361,000
|
50,000
|
$641,000 |
Corre Partners Management, Llc
|
Non-Executive |
TEAM INC (TISI)
|
2024-03-21 |
$5.83 |
209.0% |
$677,988
|
55,592
|
$324,336 |
Cormorant Asset Management, Lp
|
Non-Executive |
Ambrx Biopharma Inc. (AMAM)
|
2023-09-18 |
$9.12 |
207.1% |
$40,651,063
|
2,152,738
|
$19,625,601 |
Encrantz Staffan
|
Non-Executive Director |
Sight Sciences, Inc. (SGHT)
|
2023-11-17 |
$2.19 |
192.9% |
$536,118
|
127,003
|
$277,971 |
Levinson Sam
|
Non-Executive |
SONIDA SENIOR LIVING, INC. (SNDA)
|
2024-02-01 |
$9.50 |
192.2% |
$19,221,060
|
1,052,632
|
$10,000,004 |
Levinson Sam
|
Non-Executive |
SONIDA SENIOR LIVING, INC. (SNDA)
|
2024-03-22 |
$9.50 |
192.2% |
$9,610,530
|
526,316
|
$5,000,002 |
Duggan Robert W
|
Non-Executive Director |
Pulse Biosciences, Inc. (PLSE)
|
2023-11-17 |
$6.10 |
186.6% |
$230,343
|
20,241
|
$123,470 |
Perceptive Advisors Llc
|
Non-Executive |
SOLENO THERAPEUTICS INC (SLNO)
|
2023-09-28 |
$17.44 |
186.3% |
$28,151,858
|
866,789
|
$15,113,916 |
Ortelius Advisors, L.P.
|
Non-Executive |
SONIDA SENIOR LIVING, INC. (SNDA)
|
2023-12-21 |
$10.00 |
177.6% |
$4,770,869
|
268,630
|
$2,686,300 |
Opaleye Management Inc.
|
Non-Executive |
HARROW HEALTH, INC. (HROW)
|
2023-09-20 |
$14.60 |
174.2% |
$508,724
|
20,000
|
$292,076 |
Nerges Joseph R
|
Non-Executive |
CSP INC /MA/ (CSPI)
|
2023-12-15 |
$4.55 |
170.2% |
$561,172
|
72,552
|
$329,767 |
Encrantz Staffan
|
Non-Executive Director |
Sight Sciences, Inc. (SGHT)
|
2023-11-22 |
$2.39 |
168.7% |
$759,749
|
188,796
|
$450,433 |
Cormorant Asset Management, Lp
|
Non-Executive |
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
|
2024-02-02 |
$19.00 |
167.2% |
$23,827,500
|
750,000
|
$14,250,000 |
Corre Partners Management, Llc
|
Non-Executive |
TEAM INC (TISI)
|
2024-03-26 |
$6.87 |
162.3% |
$216,163
|
19,374
|
$133,150 |